Nucleolar Protein 1 (NOL1) 抗体 (PE-Cy5.5)
Quick Overview for Nucleolar Protein 1 (NOL1) 抗体 (PE-Cy5.5) (ABIN1437270)
抗原
See all Nucleolar Protein 1 (NOL1) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human NOL1
-
亚型
- IgG
-
-
-
-
应用备注
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Nucleolar Protein 1 (NOL1)
-
别名
- NOL1
-
背景
-
Synonyms: proliferation Associated Nucleolar Antigen: NOL 1, NUCLEOLAR ANTIGEN p120, NOP2_HUMAN.
Background: Proliferation-associated nucleolar antigen is expressed in mid G1 phase with peak level during the S phase and a rapid degradation during late mitosis. Its expression in breast carcinoma is correlated with patient prognosis.
-
分子量
- 95kDa
-
基因ID
- 4839
抗原
-